Skip to main content
. Author manuscript; available in PMC: 2010 Jan 7.
Published in final edited form as: Int J Oncol. 2009 Jan;34(1):89–96.

Figure 2.

Figure 2

(A) Treatment of human renal carcinoma cells with c-Fes siRNA inhibits the proliferation. ACHN or VMRC-RCW cells were seeded in 24-well plates and cultured in the presence of either negative control (Cont.) or c-Fes siRNA at the indicated concentrations for three days. Cells were then detached and counted. Data are expressed as means ± SD of triplicate samples. Reproducible results were obtained from four independent experiments. *P<0.05. (B) ACHN or VMRC-RCW cells were cultured for 2 days. Cells were pulse-labeled with BrdU for 4 h, and nuclei which had incorporated BrdU were visualized by immunocytochemical staining. The labeling index was determined as the labeled nuclei/total nuclei ratio × 100. Values shown are means ± SD for triplicate wells. **P<0.01. Similar results were obtained in two independent experiments.